Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IRF3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SF3B2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
PLEKHM2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
CPSF3L - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
DMAP1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
SIX5 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
AP3D1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
SSRP1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ZC3H3 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
SKIV2L - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
UBE2M - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ITGB5 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
TMEM185A - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
XAB2 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
ATG9A - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
RAVER1 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
GEO DataSets Profile neighbors
GUSB - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
POLR2A - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
SLC25A22 - Ovarian cancer xenograft tumor response to trastuzumab and pertuzumab
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on